| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096874 Oxadiazole Derivative as Dgat Inhibitors |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | US20080096872 Composition for Treatment of Pain Specification |
| 04/24/2008 | US20080096871 Schizophrenia, bipolar I disorder, agitation, borderline personality disorder; intramuscular sustained release formulations and depots |
| 04/24/2008 | US20080096870 Oral, intranasal or intravenous administration of bromophenylalanine and a neuroleptic agent; NMDA receptor agonists; schizophrenia; anxiolytic agents, antidepressants; Alzheimer's disease; bipolar disorder |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080096868 [1-(4-methoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-o-tolyl-amine for example; protein tyrosine kinase inhibitors; anticancer agents |
| 04/24/2008 | US20080096867 Imidazo[1,2-A] Pyridine Anxiolytics |
| 04/24/2008 | US20080096866 Complex Formulation Of 3-Hydroxy-3-Methyl Glutaryl Coa Reductace Inhibitor And Antihypertensive Agent, And Process For Preparing Same |
| 04/24/2008 | US20080096865 Improved photodynamic treatment against subfoveal choroidal neovascularization; administering midostaurin, vatalanib dihydrochloride or octreotide with a photosensitive porphyrin or purpurin; angiogenesis inhibition |
| 04/24/2008 | US20080096864 Partially imatinib-resistant tumors; synergistic; combined packaging; oral administration |
| 04/24/2008 | US20080096863 Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor |
| 04/24/2008 | US20080096862 Lactam compounds and pharmaceutical use thereof |
| 04/24/2008 | US20080096861 Chemical Compounds |
| 04/24/2008 | US20080096860 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 04/24/2008 | US20080096859 Compositions and Methods for Treating Ophthalmic Diseases |
| 04/24/2008 | US20080096858 Which is in an amorphous or other disordered state; freeze drying to remove water, heating within a given temperature range, optionally holding at heated temperature for up to two weeks, cooling |
| 04/24/2008 | US20080096857 Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins |
| 04/24/2008 | US20080096856 Antibiotic Compound |
| 04/24/2008 | US20080096855 Process for obtaining norelgestromin in different relations of isomers E and Z |
| 04/24/2008 | US20080096854 Orally administering edible oil homogenized with edible wax and a sterol comprising stigmasterol, campesterol, p-sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and poriferasterol to treat colorectal, stomach, and/or esophagus cancer |
| 04/24/2008 | US20080096853 Reaction product of carboxylic acid(s) with glycerol and propylene glycol; co-lipid selected from phosphorus-containing lipids and hydroxylated carboxylic esters of mono- and di-glycerides; carotenoids, fat-soluble vitamins, phytosterols, and/or phytostanols; crystal structure; foods; beverages, soups |
| 04/24/2008 | US20080096852 Use of oculosurface selective glucocorticoid in the treatment of dry eye |
| 04/24/2008 | US20080096851 (20S)-1Alpha-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and Its Uses |
| 04/24/2008 | US20080096850 Exposing Grampositive bacteria of vagina to a synergistic mixture including hexachlorophene, benzyl paraben, benzyl salicylate, a benzophenone, chlorophene, 2,4-diaminodiphenylamine, dichlorophene, HC Green No. 1, HC Orange No. 1, HC Red No. 1, isopropylbenzyl salicylate, and phenyl salicylate; tampons |
| 04/24/2008 | US20080096849 Administering balsalazide with food increases bioavailability of balsalazide and metabolites 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid; label on container recommends to take drug with food; inflammatory bowel disease, radiation enteritis, colon cancer; gastrointestinal disorders |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | US20080096847 More than one dopamine receptor agonist such as apomorphine, ropinirole, pramipexole, pergoline, cabergoline, SKF-81297; and/or more than one noradrenaline/dopamine precursor and/or more than one serotonin receptor agonist; spinal cord injuries; nervous system disorders; paraplegics or tetraplegics |
| 04/24/2008 | US20080096846 Ruthenium complexes with ligands that have a longer hydrolysis time such as azide, isothiocyanate, pyridines, thiolates; thought to bind to DNA after hydrolysis for antitumor effect; pharmacokinetics; ruthenium complex with biphenyl, ethylenediamine, azide and hexafluorophosphide for example |
| 04/24/2008 | US20080096845 Sphingomyelin therapy of autoimmune disease |
| 04/24/2008 | US20080096844 Novel inhibitors of chymase |
| 04/24/2008 | US20080096843 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example |
| 04/24/2008 | US20080096842 Preventive/Remedy for Obesity |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096840 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents |
| 04/24/2008 | US20080096839 DNA vector encoding the RNA molecules and synthesized siRNA molecules; gene expression and viral replication inhibition |
| 04/24/2008 | US20080096838 Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
| 04/24/2008 | US20080096837 Defective sindbis viral vectors |
| 04/24/2008 | US20080096836 Contacting sample of heterogenous protein from blood, lymph or cerebrospinal fluid or protein expression library such as a wound site-, a lambda wound site expression-, or a phage display library with compound from saliva or salivary glands of a blood-feeding parasite; isolating ligand or receptor |
| 04/24/2008 | US20080096835 Inhibitory oligonucleotides targeted to BCL-2 |
| 04/24/2008 | US20080096834 Administering a nucleic acid encoding a trout E-domain peptide or somatomedin as antiproliferative, anticarcinogenic and/or antitumor agent in mammals or fish |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096832 non-nucleoside HIV-1 reverse transcriptase inhibitor (NNRTI); co-administering cytochrome P450 inhibitor such as ritonavir to reduce metabolism of the NNRTI 5,11-Dihydro-11-ethyl-5-methyl-8- {2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one, (BILR 355 ) by half |
| 04/24/2008 | US20080096831 Stabilized azithromycin composition |
| 04/24/2008 | US20080096830 9a-aza-9a-Homoerythromycin derivatives with a dibenzo[e,h]azulene subunit; asthma, adult respiratory distress syndrome; gastrointestinal, respiratory system, autoimmune, genetic, skin, rheumatic, or smooth muscular disorders; inhibitors of tumor necrosis factor, interleukins, leukotrienes, lipoxygenase |
| 04/24/2008 | US20080096829 Derivatives of erythromycin A and azithromycin having quinoline, [1,3]oxazino[5,4,3-ij]quinoline, or [1,4]oxazepino[2,3,4-ij]quinoline substituent; macrolide-resistant bacterial infections; Staphylococcus, Streptopococcus, Moraxella, Hemophilus, Enterococcus, Chlamydia, Mycoplasma, or Legionella |
| 04/24/2008 | US20080096828 7-Quinolyl ketolide antibacterial agents |
| 04/24/2008 | US20080096827 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans For Use In The Prevention And Treatment Of Cognitive Decline And Age-Related Memory Impairments |
| 04/24/2008 | US20080096826 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans For Use In The Prevention And Treatment Of Cognitive Decline And Age-Related Memory Impairments |
| 04/24/2008 | US20080096825 Preparation and Use of Phlorizin Compositions |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096815 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096808 co-administering the protein replacement therapy with rapamycin, to inhibiting the immune response of a host to protein replacement therapy; immunology modulators |
| 04/24/2008 | US20080096804 contacting metal oxides and metal hydroxides with amino acids in solvents to form a solution comprising a metal hydroxyl amino acetate reaction product; foods; nutraceuticals; beverages; dairy products; drug adjuvants |
| 04/24/2008 | US20080096802 administering peroxisome proliferator-activated receptor agonists (PPAR) and sodium glucose co-transporters (SGLTs) inhibitors for the treatment of diabetes and Syndrome X |
| 04/24/2008 | US20080096799 Compounds for and methods of treating insulin resistance and inflammation |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080095869 Anticancer Treatment |
| 04/24/2008 | US20080095866 Topical Compositions Containing Phosphorylated Polyphenols |
| 04/24/2008 | US20080095865 Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance |
| 04/24/2008 | US20080095856 Encapsulated Nanoparticles for Drug Delivery |
| 04/24/2008 | US20080095855 Taste Masking Granules |
| 04/24/2008 | US20080095854 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/24/2008 | US20080095853 Modified Release For Proton Pump Inhibitors |
| 04/24/2008 | US20080095851 Phospholipid-free, having a D50 particle size of less than 500 nm, and having a surface stabilizer; improved pharmacokinetic profiles and reduced fed/fasted variability |
| 04/24/2008 | US20080095850 produces homogeneous, free flowing, attrition resistant, uniform sized granules of etoricoxib for treating pain and inflammation in patients that cannot swallow a tablet |
| 04/24/2008 | US20080095848 Pharmaceutical Composition For Topical Use In Form Of Xerogels Or Films And Methods For Production |
| 04/24/2008 | US20080095845 Comprises at least 60 weight % of an active ingredient and powdered wax having a melting point greater than 90 degrees C; produced by direct compression; has excellent disintegration |
| 04/24/2008 | US20080095844 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof |
| 04/24/2008 | US20080095843 Controlled-release formulations |
| 04/24/2008 | US20080095842 Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations |
| 04/24/2008 | US20080095841 Such as amlodipine besylate, iron oxide and carrageenan; storage stability |
| 04/24/2008 | US20080095839 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax |
| 04/24/2008 | US20080095835 Cyclin dependent kinase inhibitors; gene expression inhibition; cell differentiation; immunotherapy; cytokines |
| 04/24/2008 | US20080095834 Mitochondriotropic Phospholipid Vesicles |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095831 Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent |
| 04/24/2008 | US20080095826 Method of Increasing Peripheral Blood Lymphocytes |
| 04/24/2008 | US20080095824 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 04/24/2008 | US20080095817 Template having thereon at least one synthetic degradable extracellular matrix layer and one biomolecule releasably associated with layer, biomolecule comprising cell-affecting portion and matrix-binding portion; temporally controlling growth factor signaling and directing activities of associated cells |
| 04/24/2008 | US20080095815 Hollow and Porous Orthopaedic or Dental Implant that Delivers a Biological Agent |
| 04/24/2008 | US20080095814 Contain a phenolic antimicrobial agent, a surfactant, a hydrotrope, and a disinfecting alcohol, wherein the phenolic antimicrobial agent is present in a continuous aqueous phase in an amount of at least 25% of saturation concentration; effective in short contact time |
| 04/24/2008 | US20080095810 Nanoparticle systems for release of biologically active molecules formed by chitosan polymer or derivatives, chemically modified with polyethylene glycol and crosslinked with a crosslinking agent; especially useful for pharmaceutical compositions, vaccines and cosmetic formulations; controlled release |
| 04/24/2008 | US20080095802 Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer |
| 04/24/2008 | US20080095800 Eliciting HCV-specific antibodies |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095787 Adjuvants and methods of use |
| 04/24/2008 | US20080095786 Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions |
| 04/24/2008 | US20080095782 Using secreted glycoprotein (Lipocalin-2) for treatment of obesity and as evaluative tool in detection of glucose tolerance, insulin resistance and Type 2 diabetes in mammals |
| 04/24/2008 | US20080095779 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080095768 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/24/2008 | US20080095764 Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer |
| 04/24/2008 | US20080095763 Using cyclin dependent kinase -9 (CDK9) as diagnostic tool in identifying modulators of insulin like growth factor function; antitumor agents; antihypoxic agents |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | US20080095757 Vitamin c compositions |